Efficacy and Safety of Early Use of Everolimus in Standard and Extended Criteria Deceased Donor KidneyTransplant Recipients: 12-Month Preliminary Results of a Randomized Single Center Trial.

被引：0
|
作者：
Fernandes-Charpiot, I. [1 ,2 ]
Caldas, H. [2 ]
Mazeti, C. [2 ]
Baptista, M. [1 ,2 ]
Razera, J. [2 ]
Abbud-Filho, M. [1 ,2 ,3 ]
机构：
[1] Sao Jose do Rio Preto, Hosp Base, Fac Med, Sao Paulo, Brazil
[2] Sao Jose do Rio Preto, Lab Imunolgia & Transplante Expt, Sao Paulo, Brazil
[3] Sao Jose do Rio Preto, Inst Urol & Nefrol, Sao Paulo, Brazil
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1859
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Early Use of Everolimus in Standard and Extended Criteria Deceased Donor KidneyTransplant Recipients: 12-Month Preliminary Results of a Randomized Single Center Trial
    Fernandes-Charpiot, I.
    Caldas, H.
    Mazeti, C.
    Baptista, M.
    Razera, J.
    Abbud-Filho, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 597 - 598
  • [2] Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial
    Dantal, Jacques
    Berthoux, Francois
    Moal, Marie-Christine
    Rostaing, Lionel
    Legendre, Christophe
    Genin, Robert
    Toupance, Olivier
    Moulin, Bruno
    Merville, Pierre
    Rerolle, Jean-Philippe
    Bayle, Francois
    Westeel, Pierre Francois
    Glotz, Denis
    Kossari, Niloufar
    Lefrancois, Nicole
    Charpentier, Bernard
    Quere, Stephane
    Di Giambattista, Fabienne
    Cassuto, Elisabeth
    TRANSPLANT INTERNATIONAL, 2010, 23 (11) : 1084 - 1093
  • [3] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Suh, Kyung-Suk
    Joo, Dong Jin
    Uemoto, Shinji
    Joh, Jaewon
    Yoshizumi, Tomoharu
    Yang, Horng-Ren
    Song, Gi-Won
    Lopez, Patricia
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (06) : 1435 - 1446
  • [4] Efficacy and safety of prospidine vs methotrexate in active rheumatoid arthritis: Results of a controlled, randomized 12-month trial.
    Benenson, E
    Nemtzov, B
    Timina, O
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S369 - S369
  • [5] Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial (vol 23, pg 1084, 2010)
    Dantal, J.
    Berthoux, F.
    Moal, M-C
    Rostaing, L.
    Legendre, C.
    Genin, R.
    Toupance, O.
    Moulin, B.
    Merville, P.
    Rerolle, J-P
    Bayle, F.
    Westeel, P. F.
    Glotz, D.
    Kossari, N.
    Lefrancois, N.
    Charpentier, B.
    Quere, S.
    Di Giambattista, F.
    Cassuto, E.
    TRANSPLANT INTERNATIONAL, 2012, 25 (01) : 138 - 138
  • [6] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study (vol 18, pg 1435, 2018)
    Jeng, L-B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (10) : 2489 - 2490
  • [7] Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial
    Favi, E.
    Silvestrini, N.
    Salerno, M. P.
    Romagnoli, J.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 42 - 43
  • [8] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 80 - 80
  • [9] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80
  • [10] Efficacy and Safety of Everolimus in De Novo Liver Transplant Recipients-12 Month Results of a Randomized, Multicenter Study.
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    LIVER TRANSPLANTATION, 2012, 18 : S109 - S110
12345